Doctor Q&A

WhatsApp Facebook WeChat Weibo

Hello, my father was diagnosed with small cell lung cancer in May of this year, which has spread to other parts of his body, including the lymph nodes in his neck, liver, and brain. He has already undergone four rounds of chemotherapy at a government hospital. The doctor says the treatment is very effective, with most tumors shrinking significantly. However, the doctor recommends radiotherapy to treat the small tumors in his brain as soon as possible, scheduled for after the sixth round of chemotherapy. The doctor also suggested considering radiotherapy to the lungs, but since there is still about a 3mm tumor in his liver, even if he undergoes radiotherapy to the lungs, it will not be able to treat the other spread sites. 1. If radiotherapy is not used to treat the brain tumors, are there other options? 2. Radiotherapy to the brain carries risks such as neurodegeneration. How high are these risks? What are the risks of not receiving radiotherapy to the brain after chemotherapy? 3. Since the cancer cells have spread to other places, such as the liver, what are the consequences of not undergoing radiotherapy to the lungs? In this situation, are there other treatment options available? Thank you!

1. Studies have found that in metastatic small cell lung cancer, patients who undergo whole-brain radiotherapy can prolong survival if the tumor shrinks significantly. Recent studies have suggested localized brain radiotherapy as an alternative, but this is only suitable for patients with a small number of brain metastases and requires regular brain MRI scans to achieve similar disease control. Localized radiotherapy is recommended only for patients who can afford it and are willing to undergo frequent MRI scans.
2. Brain radiotherapy, especially whole-brain radiotherapy, can significantly lead to hair loss and negative impacts on cognitive abilities, memory, and quality of life. The downside of not undergoing any radiotherapy is the high risk of brain tumor recurrence, which can affect the patient's physical function and ultimately lifespan.

3. When tumors outside the chest cavity shrink significantly after chemotherapy, the remaining tumor in the chest cavity is very likely to be the first to become malignant. Preventive radiotherapy can prolong the patient's life, and the side effects are generally within an acceptable range. Therefore, it is recommended to perform radiotherapy whenever possible.

  • ALK gene, BRAF gene, EGFR gene, FGFR gene, HER2 gene, KRAS gene, MSI-H gene, NTRK gene, PD-L1 gene, PIK3CA gene, RET gene, ROS1 gene, Chemotherapy, Laboratory examination, Gene classification articles, Radiotherapy, lymphoma, Pathological diagnosis, Cancer treatment, Types of cancer, Cancer diagnosis, Magnetic resonance imaging (MRI), liver cancer, Lung cancer, brain cancer, Computed tomography (CT) scan